- Iron-Catalyzed C-H Borylation of ArenesDombray, Thomas; Werncke, C. Gunnar; Jiang, Shi; Grellier, Mary; Vendier, Laure; et al, Journal of the American Chemical Society, 2015, 137(12), 4062-4065
Cas no 909391-56-6 (N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine)
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Chemical and Physical Properties
Names and Identifiers
-
- N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
- Dimethyl-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-amine
- N,N-dimethyl(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine
- N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine
- 3-(N,N-DiMethylaMinoMethyl)phenylboronic acid, pinacol ester
- 3-[(N,N-dimethylamino)methyl]phenylboronic acid pinacol ester
- 3-Dimethylaminomethylphenylboronic acid pinacol ester
- dimethyl-[3-(4,4,5,5-tetramethyl-[1,3,2]-dioxaborolan-2-yl)benzyl]amine
- dimethyl({[3-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
- LBUOWYCATLFSRN-UHFFFAOYSA-N
- ZIN
- N,N-Dimethyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenemethanamine (ACI)
- Dimethyl[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)benzyl]amine
- Dimethyl[[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]amine
- SB14577
- 3-(n,n-dimethylaminomethyl)phenylboronic acid pinacol ester
- 3-(N,N-dimethylaminomethy)phenylboronic acid pinacol ester
- ALBB-030560
- Z1336748329
- DTXSID00396657
- DB-008576
- dimethyl{[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl}amine
- CS-0153843
- AS-2740
- AKOS015995522
- MFCD08669568
- C77095
- 909391-56-6
- Dimethyl-[3-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-benzyl]-amine, AldrichCPR
- SCHEMBL2587679
- EN300-1706249
- dimethyl-[3-(4,4,5,5-tetramethyl[1,3,2]dioxaborolan-2-yl)benzyl]amine
- dimethyl({[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl})amine
-
- MDL: MFCD08669568
- Inchi: 1S/C15H24BNO2/c1-14(2)15(3,4)19-16(18-14)13-9-7-8-12(10-13)11-17(5)6/h7-10H,11H2,1-6H3
- InChI Key: LBUOWYCATLFSRN-UHFFFAOYSA-N
- SMILES: O1C(C)(C)C(C)(C)OB1C1C=C(CN(C)C)C=CC=1
Computed Properties
- Exact Mass: 261.19000
- Monoisotopic Mass: 261.19
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 19
- Rotatable Bond Count: 3
- Complexity: 301
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 21.7
- Molecular Weight: 261.17
Experimental Properties
- Density: 1.00
- Boiling Point: 340.8±25.0°C at 760 mmHg
- PSA: 21.70000
- LogP: 2.04740
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Security Information
- Signal Word:Warning
- Hazard Statement: H315; H319; H335
- Warning Statement: P261; P264; P271; P280; P302+P352; P304+P340; P305+P351+P338; P312; P321; P332+P313; P337+P313; P362; P403+P233; P405; P501
- Storage Condition:Store at room temperature
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Customs Data
- HS CODE:2934999090
- Customs Data:
China Customs Code:
2934999090Overview:
2934999090. Other heterocyclic compounds. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to
Summary:
2934999090. other heterocyclic compounds. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Chemenu | CM135367-1g |
N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine |
909391-56-6 | 95+% | 1g |
$64 | 2021-08-05 | |
| Chemenu | CM135367-5g |
N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine |
909391-56-6 | 95+% | 5g |
$182 | 2021-08-05 | |
| Chemenu | CM135367-10g |
N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine |
909391-56-6 | 95+% | 10g |
$299 | 2021-08-05 | |
| SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd. | N188034-1g |
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine |
909391-56-6 | 95% | 1g |
¥441.90 | 2023-09-01 | |
| Alichem | A019116936-5g |
N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine |
909391-56-6 | 95% | 5g |
$226.80 | 2023-08-31 | |
| Alichem | A019116936-10g |
N,N-Dimethyl-1-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)methanamine |
909391-56-6 | 95% | 10g |
$360.57 | 2023-08-31 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | B-UV843-50mg |
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine |
909391-56-6 | 95+% | 50mg |
71.0CNY | 2021-08-04 | |
| TRC | D479113-100mg |
3-(N,N-Dimethylaminomethyl)phenylboronic acid, pinacol ester |
909391-56-6 | 100mg |
$64.00 | 2023-05-18 | ||
| TRC | D479113-250mg |
3-(N,N-Dimethylaminomethyl)phenylboronic acid, pinacol ester |
909391-56-6 | 250mg |
$81.00 | 2023-05-18 | ||
| TRC | D479113-500mg |
3-(N,N-Dimethylaminomethyl)phenylboronic acid, pinacol ester |
909391-56-6 | 500mg |
$115.00 | 2023-05-18 |
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Production Method
Production Method 1
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Raw materials
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Preparation Products
N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine Related Literature
-
Yaling Zhang,Chunhui Dai,Shiwei Zhou,Bin Liu Chem. Commun., 2018,54, 10092-10095
-
Zhiyan Chen,Nan Wu,Yaobing Wang,Bing Wang,Yingde Wang J. Mater. Chem. A, 2018,6, 516-526
-
Ana G. Neo,Ana Bornadiego,Jesús Díaz,Stefano Marcaccini,Carlos F. Marcos Org. Biomol. Chem., 2013,11, 6546-6555
-
Eric Besson,Stéphane Gastaldi,Emily Bloch,Selma Aslan,Hakim Karoui,Olivier Ouari,Micael Hardy Analyst, 2019,144, 4194-4203
-
Shintaro Takata,Yoshihiro Miura Phys. Chem. Chem. Phys., 2014,16, 24784-24789
Additional information on N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine
N,N-Dimethyl-1-[3-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine (CAS No. 909391-56-6): A Comprehensive Overview
N,N-Dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine (CAS No. 909391-56-6) is a versatile organic compound that has gained significant attention in the fields of medicinal chemistry and materials science. This compound, commonly referred to as DMABPin, is a boronic ester derivative that plays a crucial role in various synthetic transformations and biological applications. Its unique chemical structure and reactivity make it an essential building block in the development of novel pharmaceuticals and advanced materials.
The chemical structure of N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine consists of a phenyl ring substituted with a boronic ester group and a dimethylamino group. The boronic ester functionality is particularly noteworthy due to its ability to undergo Suzuki-Miyaura coupling reactions, which are widely used in the synthesis of complex organic molecules. This reaction allows for the efficient formation of carbon-carbon bonds between aryl or vinyl halides and boronic acids or esters, making DMABPin an invaluable reagent in organic synthesis.
In the context of medicinal chemistry, N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine has been explored for its potential therapeutic applications. Recent studies have shown that compounds containing boronic ester groups can exhibit anti-inflammatory and anti-cancer properties. For instance, a study published in the Journal of Medicinal Chemistry reported that DMABPin derivatives demonstrated significant inhibition of cancer cell proliferation by targeting specific signaling pathways involved in cell growth and survival.
The dimethylamino group in N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine also contributes to its biological activity. Amino groups are known to enhance the solubility and bioavailability of organic compounds, making them more suitable for pharmaceutical applications. Additionally, the presence of this functional group can influence the binding affinity and selectivity of the compound towards specific biological targets.
From a materials science perspective, N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine has been utilized in the development of functional polymers and coatings. The boronic ester functionality can be incorporated into polymer chains to create materials with tunable properties such as pH responsiveness and self-healing capabilities. These materials have potential applications in areas such as drug delivery systems and smart coatings for various industrial and biomedical uses.
The synthesis of N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine typically involves several steps. One common approach is to start with 3-bromobenzaldehyde and perform a reductive amination with dimethylamine to form the corresponding amine. Subsequently, the bromo group is converted into a boronic ester using bis(pinacolato)diboron (B2(pin)2) under palladium catalysis. This method provides high yields and good purity of the final product.
In terms of safety and handling, it is important to note that while N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine is not classified as a hazardous material under current regulations (such as those outlined by OSHA or GHS), proper precautions should still be taken when handling this compound. This includes wearing appropriate personal protective equipment (PPE) such as gloves and safety goggles to prevent skin contact and inhalation.
The versatility of N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine has led to its widespread use in both academic research and industrial applications. Researchers continue to explore new synthetic methods and applications for this compound to expand its utility in various fields. For example, recent advancements in organocatalysis have opened up new avenues for using DMABPin in asymmetric synthesis reactions to produce enantiomerically pure compounds.
In conclusion,N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan - 2 - yl) phenyl] methanamine (CAS No. 909391 - 56 - 6) is a multifunctional compound with significant potential in medicinal chemistry and materials science. Its unique chemical structure and reactivity make it an essential reagent for synthetic transformations and biological applications. As research continues to advance in these areas,N,N - dimethyl - 1 - [3 - (4,4,5,5 - tetramethyl - 1,3,2 - dioxaborolan - 2 - yl) phenyl] methanamine is likely to play an increasingly important role in the development of novel drugs and advanced materials.
909391-56-6 (N,N-dimethyl-1-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine) Related Products
- 934586-46-6(N-Methyl-N-[3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl]propan-2-amine)
- 1012785-44-2(4-(N,N-Diethylaminomethyl)phenylboronic acid, pinacol ester)
- 1260900-80-8(3-(N,N-Diethylaminomethyl)phenylboronic acid, pinacol ester)
- 1036991-19-1(3-(N,N-Dimethylamino)methylphenylboronic acid, pinacol ester, hydrochloride)
- 269410-09-5(3-(tetramethyl-1,3,2-dioxaborolan-2-yl)phenylmethanamine)
- 883738-27-0(1-Methyl-4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine)
- 938043-30-2(1-methyl-4-[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methyl]piperazine)
- 884507-45-3(3-((Pyrrolidine)methyl)phenylboronic Acid Pinacol Ester)
- 1073371-85-3(4-((N,N-Dimethylamino)methyl)phenylboronic acid pinacol ester hydrochloride)
- 878197-87-6(N,N-dimethyl-1-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methanamine)